ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Gelesis Holdings Inc (EM)

Gelesis Holdings Inc (EM) (GLSHQ)

0.000001
0.00
(0.00%)
終了 6月24日 5:00AM

Gelesis Holdings Inc (EM) (GLSHQ) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.000001
( - )
買値
0.00
売値
0.00
出来高
-
0.00 日の範囲 0.00
0.000001 52 週間の範囲 0.0001
時価総額
前日終値
0.000001
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 500
発行済株式数
73,335,110
配当利回り
PER
-0
1 株当たり利益 (EPS)
-0.71
歳入
12.14M
純利益
-50.39M

Gelesis Holdings Inc (EM) について

Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS... Gelesis Holdings, Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. It also offers PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, the company develops GS200 for weight loss in prediabetes and type 2 diabetes; and GS500 for functional constipation. Further, it develops pre-clinical product GS300 for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Gelesis Holdings, Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts. On October 30, 2023, Gelesis Holdings, Inc., along its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Boston, United States
設立
2026
Gelesis Holdings Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker GLSHQ. The last closing price for Gelesis (EM) was US$0. Over the last year, Gelesis (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

Gelesis (EM) currently has 73,335,110 shares in issue. The market capitalisation of Gelesis (EM) is US$73.34 . Gelesis (EM) has a price to earnings ratio (PE ratio) of -0.00.

GLSHQ 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
12001.0E-61.0E-61.0E-61671.0E-6CS
26001.0E-60.00011.0E-6140901.0E-6CS
52001.0E-60.00011.0E-674082.631E-5CS
156-0.001999-99.950.0020.021.0E-6372660.00168721CS
260-0.001999-99.950.0020.021.0E-6372660.00168721CS

GLSHQ - Frequently Asked Questions (FAQ)

What is the current Gelesis Holdings Inc (EM) share price?
The current share price of Gelesis Holdings Inc (EM) is US$ 0.000001
How many Gelesis Holdings Inc (EM) shares are in issue?
Gelesis Holdings Inc (EM) has 73,335,110 shares in issue
What is the market cap of Gelesis Holdings Inc (EM)?
The market capitalisation of Gelesis Holdings Inc (EM) is USD 73.34
What is the 1 year trading range for Gelesis Holdings Inc (EM) share price?
Gelesis Holdings Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.0001 during the past year
What is the PE ratio of Gelesis Holdings Inc (EM)?
The price to earnings ratio of Gelesis Holdings Inc (EM) is -0
What is the cash to sales ratio of Gelesis Holdings Inc (EM)?
The cash to sales ratio of Gelesis Holdings Inc (EM) is 0
What is the registered address of Gelesis Holdings Inc (EM)?
The registered address for Gelesis Holdings Inc (EM) is 501 Boylston Street, Boston, Massachusetts, 02116
What is the Gelesis Holdings Inc (EM) website address?
The website address for Gelesis Holdings Inc (EM) is www.gelesis.com
Which industry sector does Gelesis Holdings Inc (EM) operate in?
Gelesis Holdings Inc (EM) operates in the Biotechnology & Life Sciences sector

GLSHQ 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

GLSHQ Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock